CURRICULUM VITAE - Department of Population Health Sciences

PERSONAL INFORMATION:

Date of Birth: 11/13/1971

Place of Birth: Milwaukee, Wisconsin

Citizenship: United States

CURRICULUM VITAE

David J. Vanness, PhD

50 Cambridge Rd

Madison, WI 53704

608-345-0521 dvanness@wisc.edu

CURRENT APPOINTMENTS AND AFFILIATIONS:

2012-present Associate Professor (with tenure), Department of Population Health

Sciences, University of Wisconsin School of Medicine and Public Health,

Madison, Wisconsin

2012-present

2008-present

Faculty Affiliate, Department of Industrial and Systems Engineering,

University of Wisconsin - Madison, Madison, Wisconsin

Faculty Affiliate, La Follette School of Public Affairs, University of

Wisconsin - Madison, Madison, Wisconsin

2003-present Faculty Affiliate, Center for Demography and Ecology, University of

Wisconsin - Madison, Madison, Wisconsin

2004-2008;

2011-present

Affiliate Member, University of Wisconsin Comprehensive Cancer Center,

University of Wisconsin School of Medicine and Public Health, Madison,

Wisconsin – Aging in Cancer Program (2004-2005); Cancer Control and

Population Science Program (2005-2008)

PREVIOUS APPOINTMENTS AND AFFILIATIONS:

2009-2013 Visiting Scientist, Center for Health Economics, Epidemiology & Science

Policy, United BioSource Corporation, Bethesda, Maryland

2003-2012

2008-2009

2008-2009

2003-2008

Assistant Professor, Department of Population Health Sciences, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin

(on leave 12/2008-11/2009)

Research Scientist, Center for Health Economics, Epidemiology & Science

Policy, United BioSource Corporation, Bethesda, Maryland (while on leave from UW-Madison)

Scientific Director, PACE Initiative at United BioSource Corporation,

Bethesda, Maryland

Research Collaborator, Department of Health Sciences Research, Mayo

Clinic, Rochester, Minnesota

1

2001-2003

2001-2003

Assistant Professor of Health Services Research, Mayo Medical School,

Rochester, Minnesota

Senior Associate Consultant, Division of Health Care Policy & Research,

Department of Health Sciences Research, Mayo Clinic, Rochester,

Minnesota

2002-2003

1999-2001

Associate Member, Mayo Clinic Cancer Center

Associate Consultant, Division of Health Care Policy & Research, Mayo

Clinic, Rochester, Minnesota

EDUCATION:

1994-2000

1994-1996

Doctor of Philosophy, Economics, University of Wisconsin-

Madison, Madison, Wisconsin

Master of Science, Economics, University of Wisconsin-Madison,

Madison, Wisconsin

1989-1993 Bachelor of Arts, Economics (Honors) and Government, summa cum laude , Georgetown University, Washington, D.C.

FELLOWSHIPS, TRAINEESHIPS AND ASSISTANTSHIPS:

1996-1999 Trainee, Economics of Mental Health, Funded by the National

Institute of Mental Health (T32MH018029) at the University of

Wisconsin-Madison, Madison, Wisconsin

1995-1996

1994-1995

Research Assistant, Institute for Research on Poverty and La

Follette School of Public Affairs, University of Wisconsin-

Madison, Madison, Wisconsin

Fellowship, Wisconsin Alumni Research Foundation, University of Wisconsin-Madison, Madison, Wisconsin

OTHER WORK EXPERIENCE:

1993-1994 Economic Analyst, Foley & Lardner, Washington, D.C.

1989-1990 Intern, United States Senate, Washington, D.C.

HONORS AND AWARDS:

2009 Peer-Nominated Service Award, United BioSource Corporation

1999

1999

Co-recipient, Association for Health Services Research Award,

Best Pre- and Post-Doctoral Research Poster

Co-finalist, International Health Economics Association Graduate

Student Research Competition

1993

1989-1993

Elected to Phi Beta Kappa

National Merit Scholar

2

GRANT AND CONTRACT SUPPORT:

Active:

MSN176766 (PI: Vanness) 5/1/2014-9/30/2015

National Marrow Donor Program

6.0 Cal Months

Developing a Framework for Cost-Effectiveness of Hematopoietic Cell Transplantation

Contract to evaluate, assist, design and/or prioritize ongoing and future cost-effectiveness and cost research on HSC being conducted by the National Marrow Donor Program and the Center for International Bone Marrow Transplantation Research. Develop protocol and lead investigation into cost-effectiveness of allogeneic HCT for adults aged 50-70 with AML.

CE-1304-6543 (PI: Greenberg) 3/1/2014-2/28/2017 1.2 Cal Months

PCORI (Through The Alliance for Clinical Trials in Oncology Foundation)

Post-Treatment Surveillance in Breast Cancer: Bringing CER to the Alliance

The goal of the study is to evaluate patterns of outcomes under alternative post-breast cancer surveillance, develop models to optimize surveillance and prioritize future research. Prof.

Vanness’ role is to plan, design and assist in the execution of value of information analysis related to post-breast cancer surveillance in key subpopulations of interest.

1U01CA152958-01 (PIs: Mandelblatt/Trentham-Dietz) 09/01/12-08/31/15 0.6 Cal Months

Comparative Modeling: Informing Breast Cancer Control Practice & Policy

The major goal of this project under the CISNET initiative is to compare the impact of observed practice patterns to the benefits and harms of targeting new screening and adjuvant therapy modalities based on risk factors and molecular subtypes of breast cancer and to explore the impact of improving access to new services. Prof. Vanness’ role is to provide consultation on simulations of the cost-effectiveness of personalized breast cancer screening regimens and to supervise demographic analysis of non-cancer mortality for incorporation into simulations.

Role: Co-Investigator

1 R18 DK083934 (Chang) 4/11/2011 – 3/31/2016

NIH/NIDDK

0.2 Cal Months

Mother in Motion Program to Prevent Weight Gain in Overweight/Obese WIC Mothers

The Mother In Motion (MIM) project aims to prevent weight gain among African American and white overweight/obese WIC mothers18-39 years old by promoting healthy eating, physical activity, and stress management. MIM will deliver theory-based, culturally-sensitive intervention messages via a combination of DVDs featuring African American and white overweight and obese WIC mothers who will participate in a healthy lifestyle intervention patterned after MIM and peer support group teleconferences led by MSUE nutrition

(paraprofessional) educators who will be trained in motivational interviewing. Personal role is to conduct incremental cost effectiveness analysis.

1R01CA155347 (Weinberg)

NIH/NCI

8/01/2011-6/30/2016 1.2 Cal Months

Comparative Effectiveness of Virtual and Optical Colonoscopy for CRC Surveillance

3

The major goal of the project is to evaluate the test characteristics of CT colonography (CTC) for post-resection surveillance of patients with CRC and to investigate the patient acceptability and cost-effectiveness of CTC compared to optical colonoscopy in this setting.

Complete:

HHSN272200900052C (PI: Busse) 1/1/2014-6/30/2014 1.2 Cal Months

NIAID

Inter-City Asthma Consortium: Preventive Omalizumab or Step-up Therapy for Severe Fall

Exacerbations (PROSE) study (NCT01430403). The goal of the PROSE study is to determine whether step-up therapy, either as omalizumab therapy or step-up with ICS therapy, administered prior to the period of anticipated fall exacerbations, can prevent a severe asthma exacerbation as compared to current guidelines-based treatment. Prof. Vanness’ role is to estimate treatment and outcome related costs and conduct cost-effectiveness analysis.

Role: Collaborating Scientist

MSN143794 (Vanness) 7/1/2011 – 11/30/2013 3.6 Cal Months

United BioSource Corporation

Pragmatic Approaches to Comparative Effectiveness

The goal of this initiative is to develop methods for comparative effectiveness research that accurately and efficiently account for uncertainty and heterogeneity of treatment effects. The research will include methods development linking evidence synthesis, analysis of individual patient data and design of prospective studies.

1RC4HL106363 (Mullins) 9/20/2010 – 8/31/2013 1.2 Cal Months

NIH/NHLBI

Do Bayesian Adaptive Trials Offer Advantages for CER?

The major goal of this project is to determine whether Bayesian adaptive designs currently in use for early phase clinical trials are suitable for pragmatic comparative effectiveness trials. The project will use simulation methods to reanalyze a large pragmatic controlled trial (ALLHAT) to determine whether Bayesian adaptive trial design and analysis would have reached different conclusions and/or have reached conclusions in a different timeframe. Personal role is to develop mixed treatment comparison models to synthesize evidence existing at the time

ALLHAT was conducted and develop informative priors for the adaptive design.

UW-Madison (Vanness) 1/01/2011 – 12/31/2011

Project MATCH (Robert Wood Johnson Foundation)

2.4 Cal Months

$27,857

The major goal of this project is to analyze the County Health Rankings dataset using recursive partitioning methods to determine the association of county-level health factors with mortality and morbidity and determine a set of predictive health factor weights.

4

UL1RR025011 (Drezner) 08/01/2010 – 07/31/2011 0.6 Acad Months

NIH/NCRR Institutional CTSA (UW-Madison) $49,996

Pilot Grant Program: Disparities in Wisconsin’s Diabetes Outcomes: What can we learn from emerging data? (Kuo, Project PI)

The major goal of this project is to pilot test the ability to study disparities in diabetic care, control, and co-morbid conditions, using medical claim records from WHIO, a large group of commercially insured pre-diabetic patients in Wisconsin. Supported in part by grant

1UL1RR025011 from the Clinical & Translational Science Award (CTSA) program of

NCRR/NIH. Personal role is to serve as methodological “senior mentor.”

Vanness, DJ (Subcontract PI)

PACRIN-6664#R02PAPP01

4/1/05 – 12/31/08 10%

$102,460

"American College of Radiology Imaging Network #6664: National CT Colonography Trial"

Computerized tomographic colonography (CTC) employs virtual reality technology to produce two- and three-dimensional images that permit a thorough and minimally invasive evaluation of the entire colorectal structure. The objective of this study is to clinically validate CTC for detecting colorectal neoplasia in a multicenter trial. Dr. Vanness’ role was to perform a timemotion study assessing the economic cost of CTC, to integrate trial results into existing colorectal cancer screening simulations as part of the CISNET collaborative and to extend existing simulations to incorporate unique features of screening with CTC.

Richard Weindruch, Ph.D. (PI) 9/30/03-9/20/08 5%

UW Comprehensive Cancer Center $423,049

“Integrating Aging and Cancer Research in NCI-Designated Cancer Centers”

The major goal of this planning grant is to develop the interface between aging and cancer research through the University of Wisconsin Comprehensive Cancer Center. Dr. Vanness’ role was co-director of the Patterns of Care thematic area.

Marc K. Drezner (PI) 1/1/07 – 9/01/08

NIH 1UL1RR025011-01 $4,967,287

“UW-Institute for Clinical and Translational Research (ICTR)”

9%

Dr. Vanness launched the Simulation Center, which conducts cost-effectiveness and value of information (VOI) analyses to assist in setting priorities for research funding.

Vanness, D,J PhD (Subcontract PI) 9/15/02 – 9/14/08 10%

NIH R01 AG12262-7

“Evaluation of Osteoporosis Prevention in the Elderly: Benefits and Costs”

$396,335

The purpose of this grant is to assess the benefit and costs of osteoporosis prevention in the elderly, focusing on finding better ways to implement prevention strategy. Dr. Vanness’ role was to build microsimulations to study cost-effectiveness of strategies to screen and treat osteoporosis.

5

Vanness, DJ and Smith M (co-PIs)

UW Comprehensive Cancer Center

1/1/06-12/31/07

"Cancer Patients' Preferences for Uncertain Outcomes"

10%

$74,539

Current guidelines for cancer treatment are based on average (mean or median) outcomes reported from clinical trials. However, the averaging process can mask substantial heterogeneity of treatment effects that may be important for patients making crucial decisions. The specific aims of this project are: 1) to derive and validate a model of patient preferences for different levels of treatment effect heterogeneity; 2) to characterize key treatment effects for older and younger cancer patients (e.g., chance of a cure); and 3) to develop and test scenarios that capture a broad range of preferences for treatment effects. Dr. Vanness’ role was to derive a simplyparameterized treatment effect heterogeneity preference system consistent with rank-dependent utility.

Vanness, DJ and Smith M (co-PIs)

UW Comprehensive Cancer Center

"Adoption of 5FU for Colon Cancer"

1/1/06-12/31/07 5%

$25,419

This pilot project will attempt to use linked SEER-Medicare, and American Medical Association

Masterfile data to construct treatment adoption profiles for oncologists using adjuvant chemotherapy for stage II-III colon cancer in the U.S. from 1992 through 2004. Dr. Vanness’ role was to supervise construction of datasets at the oncologist level to study patterns of adoption.

Vanness, DJ (Subcontract PI) 8/1/2003-7/31/2005

NIH R21 CA10246-1

"Pharmacogenetics of Advanced Colorectal Cancer"

11%

$36,808

The major goal of the project is to use genetic polymorphism profiles to refine predictions of treatment response and survival in patients with advanced colorectal carcinoma. Dr. Vanness’ role was to incorporate this information into a medical decision making model.

PRESENTATIONS:

Peer-Reviewed Submissions:

Solano C, Slavin M, Marks DI, Cornely OA, Pagliuca A, Bow EJ, Jarque I, Garcia-Vidal C,

Sorensen S, Vanness DJ, Barrueta JA, Peral C, Kantecki M, Charbonneau C. European

Congress of Clinical Microbiology and Infectious Diseases, April 2015. Economic Evaluation of

Voriconazole versus Posaconazole as Primary Prophylaxis for the Prevention of Invasive Fungal

Infections in Patients Undergoing Allogeneic Haematopoietic Cell Transplant (oral presentation by C Solano)

20 th

Annual International Meeting of the International Society for Pharmacoeconomics and

Outcomes Research, May 2015. Levy J, Rosenberg M, Vanness DJ. “US Based Drug Cost

Parameter Estimates Using National Average Drug Acquisition Cost (NADAC)” (oral presentation by advisee J. Levy; winner of Student Research Presentation Podium Award)

6

20 th


Outcomes Research, May 2015. Bounthavong M, Bae Y, Vanness DJ, Kazerooni R and Devine

B. An Evaluation of Clinical Remission and Safety Among Biologics for Moderate-to-Severe

Crohn’s Disease: A Bayesian Network Meta-Analysis” (poster presentation)

20 th


Outcomes Research, May 2015. Arora P, Saber W, Vanness DJ. Allogeneic Peripheral Blood

Versus Bone Marrow Hematopoietic Cell Transplantation from Unrelated Donors: A Meta-

Analysis.” (poster presentation by advisee P. Arora)

2015 BMT Tandem Meetings, February 2015. Preussler JM, Mau L, Denzen EM, Majhail NS,

Farnia SA, Silver A, Meyer C, Saber W, Vanness DJ. Administrative Claims Data for Cost

Analyses in Hematopoietic Cell Transplantation: The Good, the Bad and the Ugly. (poster presentation by advisee JM Preussler).

37 th

Annual CTRC-AACR Breast Cancer Symposium, December 2014. Decker MR, Levy JF,

Wilke LG, Vanness DJ and Neuman HB. Balancing the harms and benefits of radiation therapy for DCIS: A decision analysis examining the risk of radiation-associated sarcoma. (poster presentation by advisee M. Decker)

36 th

Annual Meeting of the Society for Medical Decision Making, October 2014. Levy JF,

Decker M, Vanness DJ. Bayesian Network Meta-Analysis of DCIS Recurrence After Breast

Conserving Surgery: A Time Dependent Hazard Approach. (poster presentation by advisee J

Levy)

ASCO Breast Cancer Symposium, September 2014. Moore AH, Trentham-Dietz A, Greenberg

CC, Vanness DJ, Hampton H, Wu X, Anderson RT, Lipscomb J, Sabatino SA, Kimmick GG,

Cress RD, Fleming ST and Wilson JF. Obesity and Guideline-Concordant Systemic Therapy for Locoregional Breast Cancer. (poster presentation by advisee AH Moore)

35 th

Annual Meeting of the Society for Medical Decision Making, October 2013. Levy JF,

Vanness DJ, Wu Y, Burnside ES. “Improving Biopsy Recommendations Following

Mammography Using Random Forests” (oral presentation by advisee J. Levy; nominated for

Lusted Prize)

AcademyHealth Annual Research Meeting, Baltimore, MD, June 2013. Jackson H, Johnson K,

Mandell K, Chatterjee D and Vanness DJ. A Cost-Effectiveness Analysis of XR-NTX for the

Treatment of Opioid Dependence. (poster presentation; student class project)

International Society for Pharmacoeconomics and Outcomes Research, 18 th

Annual International

Meeting, New Orleans, Louisiana, May 2013. Basu A, Vanness DJ, Stull DA, Thompson D.

Econometric Methods for Assessing Treatment Effect Heterogeneity. (workshop presentation)



Meeting, New Orleans, Louisiana, May 2013. Levy JF, Meek PD, Rosenberg MA, Vanness DJ,

Farrell PM. Assessing Drug Costs for Use in Utilization Studies (poster presentation; advisee first author)

7

34th Annual Meeting of the Society for Medical Decision Making. Phoenix, AZ, 2012. Vanness

DJ. Combining Random Forests and Bayesian GLM for Estimation of Heterogeneous Treatment

Effects. (oral presentation)

Annual European Congress of Rheumatology EULAR 2012, Berlin, Germany, June 2012.

“Methodological Issues When Performing Mixed Treatment Comparisons in Rheumatoid

Arthritis: A Sensitivity Analysis”(Benedict A, Vanness DJ, Shaw JW and Cifaldi M. (poster presentation)

Benedict A, Kongnakorn T, Shaw JW, Marcellusi A, Vanness DJ, Gitto L, et al. PMS46

Economic Evaluation of Adalimumab for the Treatment of Early-and Late-Stage Rheumatoid

Arthritis in Italy. Value in Health. 2012;15(7):A447–A447. (poster presentation)

22 nd

European Congress for Clinical Microbiology and Infectious Diseases (ECCMID), London,

United Kingdom, April 2012. “Mixed Treatment Comparison of Randomised Clinical Trials of

Primary Prophylaxis in Allogeneic Haematopoietic Cell Transplant Recipients – Focus on

Invasive Aspergillosis” Bow EJ, Vanness DJ, Cordonnier C, Cornely OA, Marks DI, Pagliuca

A, Slavin M, Solano C, Cragin L, Shaul AJ, Sorensen S, Chambers R, Kantecki M, Weinstein D and Schlamm H. (poster presentation)

European Group for Blood and Marrow Transplantation 38 th

Annual Meeting, Geneva,

Switzerland, April 2012. “Primary Prophylaxis of Invasive Fungal Disease in Allogeneic

Hematopoietic Cell Transplant Recipients – a Mixed Treatment Comparison of Randomised

Clinical Trials” Bow EJ, Vanness DJ, Cordonnier C, Cornely OA, Marks DI, Pagliuca A, Slavin

M, Solano C, Cragin L, Shaul AJ, Sorensen S, Chambers R, Kantecki M, Weinstein D and

Schlamm H. (oral presentation by EJ Bow)

Annual Scientific Meeting of the Australasian Society for Infectious Diseases, Freemantle,

Australia, March 2012. “Cost-Effectiveness Analysis of Oral Azoles for Prophylaxis of Invasive

Fungal Infections in Australian Patients Undergoing Allogeneic Haematopoietic Cell

Transplantation” Slavin M, Marks DI, Solano C, Sorensen S, Grolman DC, Cragin L, Shaul AJ,

Vanness DJ, Weinstein D, Schlamm H, Ryan S, and Bow EJ. (poster presentation)

Australian Society of Antimicrobials 2012 Congress, February 2012, Brisbane Australia.

“Primary Prophylaxis of Invasive Fungal Disease in Allogeneic Haematopoietic Stem Cell

Transplant Recipients – a Mixed Treatment Comparison of Randomised Clinical Trials” Slavin

M, Vanness DJ, Cordonnier C, Cornely OA, Marks DI, Pagliuca A, Solano C, Cragin L, Shaul

AJ, Sorensen S, Chambers R, Kantecki M, Weinstein D, Schlamm H and Bow EJ. (oral presentation by M Slavin)


Annual European

Congress, Madrid, Spain, November 2011: “Generalized Evidence Synthesis in Comparative

Effectiveness Research: Could the Evidence Base be Broadened in Mixed Treatment

Comparisons?” Vanness DJ and Benedict A (methods workshop)

Society for Medical Decision Making, 33 rd

Annual Meeting, Chicago, IL, October 2011:

“Expected Utility Model Used to Compare the Value of Screening Versus Diagnostic

Mammography,” Wu Y, Vanness DJ, Ayvaci M, Alagoz O, Burnside ES (oral presentation by Y

Wu; finalist for innovative methods award)

8

Society for Medical Decision Making, 33 rd Annual Meeting, Chicago, IL, October 2011:

“Determining the Most Informative Mammographic Features in Breast Cancer Diagnosis by

Multidimensional Mutual Information Analysis and Bayesian Reasoning,” Wu Y, Alagoz O,

Ayvaci M, Vanness DJ, Burnside ES (poster presentation)



Meeting, Baltimore, Maryland, May 2011: “Generalized Evidence Synthesis in Comparative

Effectiveness Research: Could the Evidence Base be Broadened in Mixed Treatment

Comparisons?” Vanness DJ, Benedict A, Fahrbach K (methods workshop)

American College of Rheumatology, 74 th Scientific Meeting, Atlanta, Georgia, November 2010:

“Comparative Effectiveness of Biologic Therapies for Treating Rheumatoid Arthritis (RA) in

Patients Who Failed an Anti-Tumor Necrosis Factor Agent: A Meta-Regression Analysis,”

Benedict A, Vanness DJ, Roy S, Cifaldi M (oral presentation by DJ Vanness)


Annual European

Congress, Prague, Czech Republic, November 2010: “Calibration of a Discrete Event Simulation

Model of Natural History of HPV-Related Diseases,” Quon P, Vanness DJ, Kansal A, Hillemans

P, Largeron N, Rémy V (poster presentation)

International Society for Pharmacoeconomics and Outcomes Research, 13 th Annual European

Congress, Prague, Czech Republic, November 2010: “Methodological Considerations When

Assessing Work Productivity (WP) and Activities of Daily Living (ADL) Outcomes in

Multinational Clinical Trials in Women with Heavy and/or Prolonged Menstrual Bleeding

(HPMB) Treated with Estradiol Valerate/Dienogest (E2V/DNG)” Wasiak R, Filonenko A, Stull

DE, Kreif N, Raluy M, Ryan J, Jeddi M, Uhl-Hochgraeber K, Vanness DJ (poster presentation)


Congress, Prague, Czech Republic, November 2010: “Understanding Mixed Treatment

Comparisons (MTCs): What do the Results Mean and How Should They Be Used?” Vanness

DJ, Fleurence R, Fahrbach K (methods workshop)

Society for Medical Decision Making, 32 nd

Annual Meeting, Toronto, Canada, October 2010:

“Modeling Crosswalk Functions: A Bayesian Beta Regression Approach,” Vanness DJ, Hanmer

J (poster presentation)

26 th

International Papillomavirus Conference, Montréal, Canada, July 2010. “A Discrete Event

Simulation Approach in Modeling the Impact of HPV Vaccination and Cervical Cancer

Screening,” Quon P, Vanness DJ, Hillemans P, Largeron N, Rémy V (poster presentation)

American Society of Health Economists, Third Biennial Research Meeting, Ithaca, New York,

June 2010: “Health Utility Crosswalks: a Bayesian Beta Regression Approach,” Vanness DJ,

Hanmer J (oral presentation by DJ Vanness)

Society for Medical Decision Making, 13 th

European Meeting May 2010, Innsbruck, Austria. “A

Discrete Event Simulation Approach in Modeling the Impact of HPV Vaccination and Cervical

Cancer Screening,” Quon P, Vanness DJ, Hillemans P, Largeron N, Rémy V (poster presentation)

9



Meeting, Atlanta, Georgia, May 2010: “The Use of Observational Evidence for Comparative

Effectiveness Research: Is it Fit-For-Purpose?” Vanness DJ, Fleurence R, Fahrbach K (methods workshop)



Meeting, Atlanta, Georgia, May 2010: “Model Assumptions in Mixed Treatment Comparisons

(MTCs): Why they Matter and Why You Should Care,” Vanness DJ, Fleurence R, Fahrbach K

(methods workshop)

International Liver Congress, Vienna, Austria, April 2010: “Cost-Effectiveness Analysis of the

EASL 2009 Clinical Practice Guidelines for Management of Chronic Hepatitis B in France,

Italy, Portugal, Spain, Turkey and the United Kingdom" Vanness DJ, Singfield C, Joseph IA, van Nooten F, Agarwal K, Buti M, Çakaloğlu Y, Marinho RT, Zarski JP, Hartz S, De Cock E,

Revankar N, Raluy M, Hutt E (poster presentation)

Radiological Society of North America, RSNA 2009, Chicago, Illinois, November-December

2009: “Patient Acceptance and Tolerance of CT Colonography versus Optical Colonoscopy during the National ACRIN CT Colonography Trial,” Siewert B, Gareen I, Vanness D, Herman

B, Johnson CD, Gatsonis C (oral presentation by B Siewert)


Congress, Paris, France, October 2009: “Bayesian Generalized Linear Modelling of the

Relationship Between Health Assessment Questionnaire - Disability Index and Health Utilities

Index Mark III in Early and Late Rheumatoid Arthritis: Data from the PREMIER and ARMADA

Trials,” Vanness DJ, Roy S, Benedict A, Cifaldi M (oral presentation by A. Benedict)

American Society of Clinical Oncology, Annual Meeting, Orlando, Florida, May-June 2009:

“ACRIN 6664: Patient Acceptance and Preference of CT Colonography Compared to Optical

Colonoscopy for Colon Cancer Screening,” Siewert B, Gareen I, Vanness DJ, Herman B,

Johnson CD, Gatsonis C (poster presentation)

American Society of Health Economists, Second Biennial Research Meeting, Durham, North

Carolina, June 2008, “Recursive Partitioning Approaches to Modeling Genetics as a Source of

Treatment Effect Heterogeneity,” Vanness DJ. (oral presentation)

American Society of Clinical Oncology, Annual Meeting, Chicago, Illinois, June 2008: “Excess

Lifetime Costs Associated with Colorectal Cancer Among Elderly Medicare Beneficiaries:

Evidence from SEER-Medicare Data,” Lang K, Lines LM, Lee DW, Korn JR, Vanness DJ,

Earle C, Menzin J. (poster presentation)

International Society for Pharmacoeconomics and Outcomes Research, 13 th Annual International

Meeting, Toronto, Ontario, Canada, May 2008: “An Unbiased Overview and Understanding of the Use of Propensity Scoring in Pharmacoeconomic and Pharmacoepidemiology Research,”

Reynolds M, Hollenbeak C, Vanness DJ (methods workshop)



Meeting, Toronto, Ontario, Canada, May 2008: “Trends in Treatment Among Elderly Colorectal

10

Cancer Patients in the US: Evidence From Linked SEER-Medicare Data,” Lang K, Lines LM,

Lee DW, Korn JR, Vanness DJ, Earle C, Menzin J. (oral presentation by K Lang)



Meeting, Toronto, Ontario, Canada, May 2008: “Differences in Colorectal Cancer Treatment

Costs by Treatment Phase, Cancer Site, and Stage at Diagnosis: Evidence from Linked SEER-

Medicare Data,” Lang K, Lines LM, Lee DW, Korn JR, Vanness DJ, Earle C, Menzin J. (poster presentation)

Academic Surgical Congress, Huntington Beach, California, February 2008: “A Qualitative

Study of Factors Which Influence Patient Choice Between Open and Endovascular Abdominal

Aortic Aneurysm (AAA) Repair,” Schwarze M, Pandhi N, Swedlund M, Gawin D, Vanness DJ,

Smith M. (oral presentation by M Schwarze)

Society for Medical Decision Making, 29 th Annual Meeting, Pittsburgh, Pennsylvania, October

2007: “Modeling Co-Occurring Health Conditions to Predict Health Utility from Generic Health-

Related Quality of Life Indices,” Hanmer J, Vanness DJ, Gangnon R, Fryback DG. (oral presentation by J Hanmer)

Society for Medical Decision Making, 29 th

Annual Meeting, Pittsburgh, Pennsylvania, October

2007: “Does Domain-Based Modeling of Multiple Health Conditions Improve Health-Related

Quality of Life Estimates Compared to Summary-Score-Based Modeling for the SF-6D?”

Hanmer J, Gangnon R, Vanness DJ, Fryback DG. (oral presentation by J Hanmer)

American Society of Health Economists, First Biennial Research Conference, Madison,

Wisconsin, June 2006: "Properties of Treatment Effect Estimates in Switching Regime Models:

Impacts of Sample Size and Strength and Dirtiness of Instruments," Henk HJ, Crown W,

Vanness DJ. (oral presentation by HJ Henk)

International Health Economics Association, Fifth World Congress, Barcelona, Spain, July 2005:

"Sensitivity of IV Estimators to Alternative Correlation Assumptions: Some Simulation-Based

Examples," Crown W, Henk HJ, Schultz J, Vanness DJ. (oral presentation by HJ Henk).


"Do Race and Ethnicity Determine Prescription Drug Use and Expenditures?" Shah N, Mullahy

J, Rosenberg M, Smith MA, Vanness DJ. (oral presentation by N Shah).


"Characterizing the Relationship Between Physiological Dysregulation and Health as a

Simultaneity Problem: a Nonparametric Bounds Approach," Seplaki CL, Vanness DJ. (poster presentation)

AcademyHealth, Annual Research Meeting, Boston, MA, June 2005: “My Own Benevolent

Dictator: Merging Rank Dependent Utility with Social Welfare Functions to Improve Policy

Making and Individual Treatment Decisions,” Vanness DJ, Smith MA. (oral presentation by DJ

Vanness)

11

AcademyHealth, Annual Research Meeting, Boston, MA, June 2005: “Patients’ Preferences for

Participation in Decision Making," Flynn KE, Smith MA, Vanness DJ. (oral presentation by KE

Flynn)

American Academy of Orthopaedic Surgeons, Annual Meeting, Washington DC, 2005: “Effects of Hospitalist and Orthopedic Co-Management of Elderly Patients with Hip Fracture,” Phy MP,

Vanness DJ, Melton LJ. (oral presentation by M Phy),

Third International Shared Decision Making Conference, Ottawa, Canada, June 2005: "Patients'

Preferences for Participation in Decision Making," Flynn KE, Smith MA, Vanness DJ. (oral presentation by KE Flynn)

AcademyHealth, Annual Research Meeting, San Diego, California, June 2004 : “Predicting

Persistently High Primary Care Use," Naessens JM, Baird MA, VanHouten HK, Vanness DJ,

Campbell CR. (oral presentation by JM Naessens).

Society of Actuaries Prescription Drug Symposium, Anaheim, California, May 2004:

"Determinants of Prescription Drug Utilization: The Role of Race and Ethnicity," Shah ND,

Rosenberg MA, Mullahy J, Smith MA, Vanness DJ. (oral presentation by ND Shah)

International Health Economics Association, Fourth World Congress, San Francisco, June 2003:

“Using Expected Social Welfare Functions to Evaluate Uncertain Technology: The Example of

DNA-Based Stool Testing for Colorectal Cancer," Vanness DJ. (oral presentation by DJ

Vanness)

International Health Economics Association, Fourth World Congress, San Francisco, June 2003:

“A Minimum Distance Method for Calibrating Cost-Effectiveness Simulations to Observed

Epidemiological Data: The Case of Colorectal Cancer Screening,” Vanness DJ. (oral presentation by DJ Vanness)

Mid-America Orthopaedic Association, Twenty-First Annual Meeting, Hilton Head, South

Carolina, April 2003: “Partnering for Optimal Patient Care: Prospective, Randomized,

Controlled Trial of the Inpatient Experience of a Hospitalist Orthopedic Team (HOT),”

Huddleston JM, Larson D, Vanness DJ, Long KH, Plevak M, Ilstrup DM, Naessens JM,

Trousdale RT, Cabanela ME, Wachter R. (oral presentation by JM Huddleston)

Eleventh European Workshop on Econometrics and Health Economics, Lund, Sweden,

September 2002: “A Structural Model of Family Valuation and Choice Of Employer-Sponsored

Health Insurance In The United States,” Vanness DJ. (oral presentation by DJ Vanness)

International Liver Transplantation Society, 8th Annual Congress, Chicago, Illinois, June 2002:

“Employment and Health Insurance of Long-Term Liver Transplant Recipients,” Kim WR,

Vanness DJ. (oral presentation by WR Kim)

Academy for Health Services Research and Health Policy, Annual Research Meeting,

Washington, DC, June 2002: “Factors Associated with Long Run Employment after Liver

Transplant,” Vanness DJ, Kim WR, Malinchoc M. (poster presentation)

12


Washington, DC, June 2002: “Long-run Employment and Health Insurance Status of Liver

Transplant Recipients,” Kim WR, Vanness DJ, Malinchoc M. (poster presentation)


Washington, DC, June 2002: “Experience of Collecting Long-term Detailed Cost and Utilization

Data in a Prospective Economic Evaluation of a Randomized Controlled Trial,” Myhre D,

Huddleston JM, Long KH, Naessens JM, Vanness DJ, Van Grevenhof P, Rahman A. (poster presentation)

Tenth European Workshop on Econometrics and Health Economics, London, United Kingdom,

September 2001: “Empirical Modeling, Simulation and Uncertainty Analysis Using Markov

Chain Monte Carlo: Ganciclovir Prophylaxis in Liver Transplantation,” Vanness DJ, Kim WR.

(oral presentation by DJ Vanness)

Digestive Disease Week, Atlanta, Georgia, May 2001: “Discrete Event Simulation of the Cost-

Effectiveness of Colorectal Cancer Screening by a DNA-based Stool Test Relative to Current

Screening Practice,” Vanness DJ, Ahlquist DA. (poster presentation)

International Society for Pharmacoeconomics and Outcomes Research, Third Annual European

Conference, Antwerp, Belgium, November 2000: “Cost-effectiveness of Ganciclovir in

Prevention of Cytomegalovirus Disease after Liver Transplantation: A Bayesian Approach,”

Vanness DJ, Kim WR. (poster presentation)

Fourth Annual Minnesota Health Services Research Conference, Minneapolis, Minnesota,

February 2000: “Family Valuation of Employer Sponsored Health Insurance,” Vanness DJ. (oral presentation by DJ Vanness)

Association for Health Services Research, Annual Research Meeting, Chicago, IL, June 1999:

“Patterns of TCA and SSRI Prescription by Plan, Provider and State: Do Medicaid Managed

Care Members Receive Different Treatment?” Seplaki CL, Vanness DJ. (poster presentation)

International Health Economics Association Conference, Second International Meeting,

Rotterdam, Netherlands, June 1999: “Trends in Employer Sponsored Insurance: How Have

Low-Wage and High-Cost Workers Fared?” Vanness DJ, Wolfe BL. (oral presentation by DJ

Vanness)

National Institute of Mental Health, Ninth Biennial Research Conference on the Economics of

Mental Health, Bethesda, Maryland, September 1998: “Patterns of TCA and SSRI Prescription by Plan, Provider and State,” Seplaki CL, Vanness DJ. (oral presentation by CL Seplaki)

Association for Health Services Research, Annual Research Meeting, Washington, D.C., June

1998: “The Nondiscrimination Law and Health Insurance: For Whom Did it Increase

Coverage?” Vanness DJ, Wolfe BL. (poster presentation)

Allied Social Sciences Association, Annual Meeting, American Economics Association session,

Chicago, IL, January 1998: “The Nondiscrimination Law and Health Insurance: For Whom Did it Increase Coverage?” Vanness DJ, Wolfe BL. (oral presentation by DJ Vanness)

13

National Institute of Mental Health Conference on Improving the Condition of People with

Mental Illness: The Role of Services Research, Washington, D.C., September 1997: “The

Nondiscrimination Law and Health Insurance: Did It Increase Coverage Among Families With

Chronic Illness?” Vanness DJ, Wolfe BL. (poster presentation)

Invited Oral Presentations:

Northwestern University Institute for Public Health and Medicine, June 2015. “Betting on Better

Health: The Rising Importance of Bayesian Analysis in Health Economics and Outcomes

Research”

Wisconsin Cancer Council, May 2015. “Why Does Cancer Care Cost So Much, and What Can

We Do About It? (plenary)

University of Wisconsin Carbone Cancer Center Fall Cancer Symposium, October 2014. “Why

Does Cancer Care Cost So Much, and What Can We Do About It? (plenary)

Janssen Scientific Affairs, Titusville, NJ, “Introduction to Multilevel Modeling” October 2013.

Vanness DJ. (half-day methods workshop)

Merck & Co. Global Health Outcomes, Lansdale PA, “Comparative Effectiveness Research

Methods Workshop” July 2013. Paramore C, Ishak KJ and Vanness DJ (half-day methods workshop)

Mathematica Policy Research Center on Health Care Effectiveness Issue Forum “The Promise of

Orthogonal Design for Comparative Effectiveness Research” Washington, DC, April 2012.

(invited panel member with Brown R, Zurovac J, Dey K and Segal J)

Center for Medical Technology Policy, Comparative Effectiveness Research Institute, Santa Fe,

New Mexico, July 26-27, 2011: “Applying Bayesian and Adaptive Techniques for CER,” Luce

B, Ishak KJ, Connor J and Vanness DJ. (half-day methods workshop)

Janssen Scientific Affairs, Titusville, NJ, “Introduction to Bayesian Analysis for Health

Economics and Outcomes Research” June 2011. Hollenbeak C and Vanness DJ. (half-day methods workshop)

University of Arkansas Medical School, Division of Pharmaceutical Evaluation & Policy

Seminar Series, October 29, 2010: “Comparative Effectiveness Research: Back to Bayes-ics,”

Vanness DJ.

University of Rochester School of Medicine and Dentistry, Department of Community &

Preventive Medicine, June 21, 2010: "An Introduction to Bayesian GLM Methods for

Cost-Effectiveness Analysis,” Vanness DJ.

AcademyHealth, 26 th

Annual Research Meeting, Chicago, IL, June 2009: “An Introduction to

Bayesian GLM Methods for CEA with Individual Data,” Vanness DJ.

14

International Society for Pharmacoeconomics and Outcomes Research Annual International

Meeting, Orlando, Florida, May 2009: “Building off the Existing Evidence (aka: The world may be flat, but is the prior?)” Vanness DJ.

AcademyHealth, 25 th Annual Research Meeting, Washington, DC, June 2008: “Bayesian GLM

Models for Analysis of Primary Cost-Effectiveness Data,” Vanness DJ.

Dartmouth Institute Graduate Program, Visiting Faculty Doctoral Seminar, Lebanon, NH,

December 2007: “Simulation Methods and Economic Evaluation,” Vanness DJ.

Dartmouth Institute in Health Policy and Clinical Research, Lebanon, NH, December 2007:

“Different Strokes for Different Strokes: Bayesian and Recursive Partitioning Methods for

Comparative Effectiveness and Cost-Effectiveness Analysis when Treatment Effects are

Heterogeneous,” Vanness DJ.

UW Department of Biostatistics and Medical Informatics, Seminar on Bayesian Model

Averaging, Madison, WI, November 2007: “Different Strokes for Different Strokes: Bayesian and Recursive Partitioning Methods for Comparative Effectiveness and Cost-Effectiveness

Analysis when Treatment Effects are Heterogeneous,” Vanness DJ.

AcademyHealth, Annual Research Meeting, Orlando, FL, June 2007: “Different Strokes for

Different Folks: Bayesian Approach to Heterogeneous Treatment Effects in Empirical Cost-

Effectiveness Analysis,” Vanness DJ.

Federal Trade Commission, Bureau of Economics Roundtable on the Economics of the

Pharmaceutical Industry, Washington, DC, October 2006: “Invited Comments on Surplus

Appropriation from R&D and Health Care Technology Assessment Procedures by Tomas J

Philipson and Anupam B. Jena,” Vanness DJ.

UW GI Translational Cancer Working Group, Madison, WI, September 2006: “Costeffectiveness of Colorectal Cancer Screening with Virtual Colonoscopy,” Vanness DJ.

University of Wisconsin Liver Transplant Program Retreat, Madison, WI, September 2006:

“Ethics and Economics of Health Care Rationing,” Vanness DJ.

University of Wisconsin, Dept. of Population Health Sciences Seminar, November 2005:

“Different Strokes for Different Folks: Making Decisions When Treatment Effects and

Preferences are Heterogeneous,” Vanness DJ

University of Wisconsin, Robert Wood Johnson Health and Society Scholars Seminar, Madison,

WI, October 2005: “Cost-Effectiveness and Health Technology,” Vanness DJ.

University of Wisconsin, Dept. of Surgery Grand Rounds, Madison, WI, July 2005: “Ten Things

Every Surgeon Should Know about Health Economics,” Vanness DJ.

CISNET (Cancer Intervention and Surveillance Network) Annual Meeting, Potomac, MD,

November 2004: "An Update on the ACRIN-6664 Trial," Vanness DJ.

15

Virtual Colonoscopy Symposium, Boston, MA, October 2004: "Paths to Implementation: Cost and Cost-Efficacy," Vanness DJ.

Marshfield Clinic Health Care Symposium, Marshfield, WI, October 2004: “Comments on

Barriers to Health Care Access,” Vanness DJ.

CISNET (Cancer Intervention and Surveillance Network) Colorectal Cancer Screening Meeting,

New York, NY, June 2004: "Modeling the Cost-Effectiveness of CT Colonography," Vanness

DJ.

Pharmacy Society of Wisconsin Educational Conference, Madison, Wisconsin, April 2004:

"Quality and Cost: Health Care's Chicken and Egg,” Vanness DJ.

Mayo Clinic College of Medicine Grand Rounds, Rochester, Minnesota, February 2004: "CT

Colonography: Could it be Cost-Effective?" Vanness DJ.

Dartmouth College Center for the Evaluative Clinical Sciences Graduate Program, Hanover,

New Hampshire, November 2003: "Use of Simulations in Economic Analysis," Vanness DJ.

Health Economics in Rheumatology: An International Conference, Rochester, Minnesota, April

2003: “Knowing What You Don’t Know: Bayesian Approaches to Uncertainty in Economic

Evaluations,” Vanness DJ.

Colorectal Cancer Summit, Minnesota Colorectal Cancer Consortium, Minneapolis, Minnesota,

March 2003: “What Will It Cost to Screen Those We Are Trying to Reach?” Vanness DJ.

Conference on Health Services Research, Arizona State University, Tempe, Arizona, April 2002:

“The Rochester Epidemiology Project and Olmsted County Healthcare Expenditure and

Utilization Database: Tools for Health Services Research,” Vanness DJ.

Neuroscience Conference, Mayo Clinic, Scottsdale, Arizona, April 2002: “The Not So NICE

Story About Interferon Beta in the UK: or ‘What is Cost-Effectiveness Analysis and Why Should

We Care?’” Vanness DJ.

Colorectal Cancer Summit, Minnesota Colorectal Cancer Consortium, Minneapolis, Minnesota,

March 2002: “Colorectal Cancer: Cost Considerations,” Vanness DJ.

Third International Conference of the International Health Economics Association, York, United

Kingdom, July 2001: Discussant of Monheit AC and Vistnes JP “The Demand for Dependent

Health Insurance: How Important is the Marginal Cost of Family Coverage?”

Allied Social Science Associations Annual Meeting, American Economics Association session,

New Orleans, Louisiana, January 2001: Discussant of Berndt E et al, “Economic Issues in

Comparing Antidepressant Drug Therapy, Psychotherapy, and their Combination for the

Treatment of Chronic Depression.”

Mayo Foundation Managed Care Leadership Conference, Rochester, Minnesota,

August 2000: “The Perils of Outcomes Research,” Vanness DJ.

16

Internal Medicine Outcomes Research Group, Mayo Clinic, Rochester, Minnesota, March 2000:

“Confidence Intervals for Cost-Effectiveness Analysis: A Comparison of Bootstrapping versus

Bayesian Simulation Methods,” Kim WR and Vanness DJ.

PROFESSIONAL SERVICE:

2015 Ad hoc reviewer, UK Medical Research Council, research grant program

2015-present

2015-present

2014

2013-present

President, American Association of University Professors,

UW-Madison Chapter

Member, Higher Education Council, American Federation of

Teachers -- Wisconsin

Ad hoc reviewer, NIH Director’s Early Independence Award

2013-present

2010-present

2006-present

Member, Editorial Board, Medical Decision Making

Panel Member, National Institutes of Health, Health Services

Outcomes and Delivery

Mentor, Society for Medical Decision Making

2010-2013

2011, 2012

Member, Outcomes and Economics Committee, American

College of Radiology Imaging Network

Co-Chair, Health Econometrics Working Group

(International Society for Pharmacoeconomics and Outcomes

Research)

Ad hoc reviewer, Health Technology Assessment

Methodology Programme, ZonMw the Netherlands

Organisation for Health Research and Development

2010-2012

2011

2008

2004-2006

Co-Chair, Health Outcomes/Metrics Education Working

Group (International Society for Pharmacoeconomics and

Outcomes Research)

Panel member, NCI Scientific Review Meeting for

Population-based Research Optimizing Screening through

Personalized Regimens (PROSPR) (U54)

Member, Scientific Review Committee and Session Co-

Chair, Society for Medical Decision Making 30 th

Annual

Meeting

Member, Biennial Conference Local Organizing Committee,

American Society of Health Economists

2003

2000-2001

Contributed Research Abstract Review Committee for the

ISPOR Eighth Annual International Meeting

Member, Board of Directors, Laboratory Control LTD Health

Service Medical Research Fund, Ottumwa, Iowa

17

PROFESSIONAL MEMBERSHIP:

1999-present American Economics Association

1999-present

2000-present

International Health Economics Association

International Society for Pharmacoeconomics and Outcomes

Research

2001-present

2004-present

2006-present

1998-2008

2005-2008

Society for Medical Decision Making

American Society of Health Economists

International Society for Bayesian Analysis

AcademyHealth

American Society for Bone and Mineral Research

SERVICE AS REFEREE:

American Journal of Managed Care, American Journal of Preventive Medicine, Annals of

Internal Medicine, Annals of Surgery, Arthritis and Rheumatism, Arthritis Care and Research,

Clinical Gastroenterology and Hepatology, Clinical Trials - Journal of the Society for Clinical

Trials, Medical Research Methodology, Epidemiology Research International, Health

Economics, Journal of the American Medical Association, Journal of Comparative Effectiveness

Research, Journal of Mental Health Policy and Economics, Journal of the National Cancer

Institute, Liver Transplantation, Mayo Clinic Proceedings, Medical Decision Making,

Pharmacoeconomics, Preventing Chronic Disease, Social Science and Medicine, Tobacco

Control, Value in Health

INSTITUTIONAL COMMITTEE MEMBERSHIPS (* denotes current membership):

University of Wisconsin - Madison:

Committee on Faculty Rights and Responsibilities (Temporary Appointment Spring 2016)

Professional Representation Organization of the Faculty Senate (PROFS) Steering Committee*

Advanced Computing Initiative Oversight Committee*

UW-ICTR Community Academic Partnerships Steering Committee

Cancer and Aging Program Committee

Faculty Senate

Department of Population Health Sciences, UW-Madison

Executive Committee*

Curriculum Committee*

Chair, Qualifying Exam Committee*

Chair, Outcomes Research Faculty Search Committee

Admission and Recruitment Committee

Strategic Planning Committee

Infectious Disease Epidemiology Faculty Search Committee

Health Innovations Program Faculty Search Committee

Work Environment Committee

18

Mayo Clinic, Rochester:

Blue Cross Blue Shield of Minnesota Contract Review Team; Integrated Analysis Office

External Trends Work Group; Integrated Analysis Office Patient Mix Work Group; Integrated

Analysis Office High Impact Procedures Work Group; Multi-Year Fee Setting Strategy Work

Group; Hospital Health Care Safety Team; Patient Data Coordination Work Group; Health

Sciences Research, Research Committee; Health Sciences Research, Education Committee;

Annual Institutional Fee Adjustment Work Group; Fee Committee; Employee Health Care

Delivery Task Force; Clinical Practice Committee, Managed Care Operations Subcommittee;

Congestive Heart Failure Initiative Task Force; Mayo Asthma Guidelines Implementation Core

Group; Internal Medicine, Outcomes Research Group

OTHER PUBLIC SERVICE:

2014-present Member, Finance Committee, Madison Waldorf School

EDUCATIONAL ACTIVITIES:

Training Programs:

2007-present Co-Director, T32MH018029 (Economics of Mental Health), with John Mullahy and Barbara L. Wolfe

2005; 2007-2008 Co-Director, Merck Fellowship in Health Economics, with

John Mullahy, Director and Dennis L. Fryback, Co-Director

Mentoring:

National Science Foundation /

Committee on Institutional

Cooperation Alliances for

Graduate Education and the

Professoriate Professorial

Advancement Initiative

UW Institute for Clinical and

Translational Research KL2

Fulbright U.S. Scholar

Program

Marquita Decker, MD

Michael Repplinger, MD

Marquita Decker, MD

Chair, Doctoral Thesis Advisory Committee:

2014 Justin Lo

Health Economics

Health services and outcomes research.

Health services and outcomes research

Population Health Sciences (Co-Chair with Mari Palta)

19

2013

2013

2012

2007

2007

2006

2006

2006

2006

2005

2005

2005

2003

2010

2009

2008

2008

2008

2008

2007

2007

2007

2003

Member, Doctoral Thesis Advisory Committee:

Date of Completion Student

TBD

TBD

Evan Nelson

Lina Vera-Cala

TBD

2015

Jessica Cathey Smith

Hollis Moore

2015

2015

2014

2014

2013

2013

Heide Jackson

Ifna Ejebe

Kimberly Johnson

Kara Mandell

Sarah Meier

Jia Pu

Lauren Wisk

Elise Wu

Daniel Pinto

Dan Wei

CM Schussler-Fiorenza

Nathan Tefft

Richard Dunn

Brian Harahan

Theresa Hoeft

Kirstie Danielson

Cecelia Bellcross

Janel Hanmer

Perri Morgan

Marlon Mundt

Katherine Sullivan-Dillie

Tim Classen

Lauren Olsho

Kathryn Flynn

Lin Wang

Ritesh Banerjee

Nilay Shah

Elise Gould

Henry Henk

20

Discipline

Clinical Investigation

Population Health Sciences



Sociology / Demography





Social and Administrative

Pharmacy


Industrial and Systems

Engineering

Physiotherapy (University of

Otago, New Zealand)

Economics


Economics

Economics








Committee Degree

Economics

Economics


Biostatistics

Economics


Economics


Chair, Master's Thesis Advisory Committee:


TBD

2015

2015

2008

2007

2006

Ryan Schmocker

Hanyang Chen

Rosa Mak

Sarina Schrager

2004 Michael Phy

Member, Master's Thesis Advisory Committee:


2013 Hollis Moore

2010

2006

2005

2005

Andrew Peterson

Michael Gilbert

Parthiv Vora

Amy Albanese

2005 Tara Breslin

Didactic Coursework:

Date/Term Role/Responsibility Title

Spring 2009-

2015;

Fall 2005-2007

Spring 2004

Fall 2013-2015

Fall 2015

Stephanie Karpinski

Heide Jackson

Director and

Lecturer / 15 2.5hour lectures

(2009-2015); 30

1.25 hour lectures

(2004-2007)

Director and

Lecturer (4-12 lectures)

Director and

Lecturer (4 lectures)

PHS 875

Assessment of

Medical

Technologies

PHS 795

Introduction to

Population Health

Sciences

Discipline


(Soc/Demography PhD)


(Soc/Demography PhD)





Clinical Research (Mayo Clinic)

Discipline







PHS 650-029

Principles of

Population Health

Sciences

Location

Department of Population

Health Sciences, University of

Wisconsin School of Medicine and Public Health







Fall 2015 Lecturer (1 lecture) EPS 7803 Department of Educational

Policy Studies, UW-Madison

21

Fall 2014-2015 Lecturer (2 lectures)

Seminar on Scholar

Activism

PHS 805

Epidemiology 4

(Advanced

Methods)

Fall 2013-2015 Lecturer (1 lecture); Discussion

Group Facilitator

PHS 717

Introduction to Cost-

Effectiveness and

Comparative

Effectiveness

Research

Fall 2013







Lecturer (1 lecture) SOC 370 Population

Problems

Department of Sociology,

University of Wisconsin-

Madison

5/2014; 5/2013;

5/2012; 5/2011;

5/2010; 5/2009;

5/2008; 5/2007;

5/2006; 5/2005;

5/2004

Spring 2013;

Spring 2011;

Spring 2007

3/2014; 3/2013;

3/2012; 3/2011;

3/2010

11/2012;

11/2011;

11/2010;

11/2008;

11/2007

Fall 2012;

Fall 2010;

Spring 2008

5/2011

Co-Director and

Lecturer / Full-day workshop


Lecturer / 1 1.25hour session


Co-Facilitator / 2 1hour discussion sessions; Lecturer 1

1.25 hour session

Director and

Lecturer / Half-day workshop

Bayesian Analysis:

Applications

ECON 848: Health

Economics

PHS 785: Health

Systems,

Management and

Policy

PHS 795: Principles of Population Health

Science







PHS 717:

Introduction to

Epidemiology

Bayesian Analysis:

Advanced

International Society for

Pharmacoeconomics and

Outcomes Research Annual

International Meeting Short

Course

Department of Economics,

University of Wisconsin-

Madison




International Society for

Pharmacoeconomics and

Outcomes Research Annual

International Meeting Short

Course

22

4/2011; 3/2010

Spring 2008

6/2008; 6/2007;

6/2006

4/2008; 4/2007;

4/2006


Director and


Co-Director and

Lecturer / Full-day workshop

Lecturer / 1 1-hour lecture

PHS 796:

Introduction to

Health Services

Research




PA881: Cost Benefit

Analysis

La Follette School of Public

Affairs, University of

Wisconsin-Madison

Introduction to

WinBUGS

AcademyHealth Annual

Research Meeting Short Course

Spring 2008;

Fall 2007;

Fall 2006;

Spring 2006;

Spring 2005

2/2008

Spring 2007;

Spring 2006;

Spring 2005

Spring 2005

Co-Facilitator / 15

2-hour sessions

Lecturer / 1 1.25hour lecture



PHS 375:

Introduction to

Population Health

Sciences

ECON 845 (Fall) and ECON 846

(Spring): Seminar in

Health and Mental

Health Economics

PHS 650:

Introduction to the

American Health

Care System

PHS 650:

Introduction to the

American Health

Care System

PHS 650:

Population Health

Sciences: Concepts

& Methods
















Spring 2003;

Spring 2002;

Spring 2001;

Spring 2000

Spring 2002

Co-Director and

Lecturer / 4 1-hour lectures

Director and

Lecturer / 5 1-hour lectures

HSR5000:

Introduction to

Health Services

Research

Mayo Graduate School of

Medicine

Introduction to

Economic

Evaluation of Health

Care

Mayo Clinic Scottsdale

23

BIBLIOGRAPHY:

Peer-Reviewed Articles:

Vanness DJ, Wolfe BL. Government mandates and employer-sponsored health insurance: Who is still not covered? Int J Health Care Finance Econ. 2002; 2(2):99-135.

Vanness DJ, Kim WR. Bayesian estimation, simulation and uncertainty analysis: The costeffectiveness of ganciclovir prophylaxis in liver transplantation. Health Econ. 2002; 11(6):551-

566.

Paya CV, Wilson JA, Espy MJ, et al. Preemptive use of oral ganciclovir to prevent cytomegalovirus infection in liver transplant patients: A randomized, placebo-controlled trial. J

Infect Dis. 2002; 185(7):854-860.

Vanness DJ. A structural econometric model of family valuation and choice of employersponsored health insurance in the United States. Health Econ. 2003; 12(9):771-790.

Kamath CC, Kremers HM, Vanness DJ, O'Fallon WM, Cabanela RL, Gabriel SE. The costeffectiveness of acetaminophen, NSAIDs, and selective COX-2 inhibitors in the treatment of symptomatic knee osteoarthritis. Value Health. 2003; 6(2):144-157.

Fatourechi V, Lankarani M, Schryver PG, Vanness DJ, Long KH, Klee GG. Factors influencing clinical decisions to initiate thyroxine therapy for patients with mildly increased serum thyrotropin (5.1-10.0 mIU/L). Mayo Clin Proc. 2003; 78(5):554-560.

Huddleston JM, Long KH, Naessens JM, et al. Medical and surgical comanagement after elective hip and knee arthroplasty: A randomized, controlled trial. Ann Intern Med. 2004;

141(1):28.

Vanness DJ, Tosteson ANA. Estimating the opportunity costs of osteoporosis in the United

States. Top Geriatr Rehabil. 2005; 21:4-16.

Vanness DJ, Tosteson ANA, Gabriel SE, Melton LJ,3rd. The need for microsimulation to evaluate osteoporosis interventions. Osteoporos Int. 2005; 16(4):353-358.

Phy MP, Vanness DJ, Melton LJ,3rd, et al. Effects of a hospitalist model on elderly patients with hip fracture. Arch Intern Med. 2005; 165(7):796-801 [Advisee First Author].

Rongey C, Bambha K, Vanness D, et al. Employment and health insurance in long-term liver transplant recipients. Am J Transplant. 2005; 5(8):1901-1908.

Naessens JM, Baird MA, Van Houten HK, Vanness DJ, Campbell CR. Predicting persistently high primary care use. Annals of Family Medicine. 2005; 3(4):324.

Flynn KE, Smith MA, Vanness D. A typology of preferences for participation in healthcare decision making. Soc Sci Med. 2006; 63(5):1158-1169 [Advisee First Author].

24

Breslin TM, Mahvi DM, Vanness DJ, Mullahy J. Surgical work output: Is there room for increase? An analysis of surgical work effort from 1999 to 2003. J Surg Res. 2008; 146(1):90-95

[Advisee First Author].

Pickhardt PJ, Hanson ME, Vanness DJ, Lo JY, Kim DH, Taylor AJ, Winter TC and Hinshaw JL.

Unsuspected extracolonic findings at screening CT colonography: Clinical and economic impact.

Radiology. 2008; 249(1):151-159.

Hanmer J, Vanness DJ, Gangnon R, Palta M, Fryback DG, Three methods tested to model SF-

6D health utilities for health states involving comorbidity/co-occurring conditions. J Clin

Epidemiol. 2010; 63(3):331-341 [Advisee First Author].

Mossman D, Bowen MD, Vanness DJ, Bienenfeld D, Correll T, Kay J, Klykylo WM, Lehrer DS.

Quantifying the accuracy of forensic examiners in the absence of a diagnostic ‘gold standard.’

Law Hum Behav. 2010; 34(5):402-417

Bounthavong M, Zargarzadeh A, Hsu DI and Vanness DJ. Cost-effectiveness analysis of linezolid, daptomycin, and vancomycin in methicillin-resistant Staphylococcus aureus complicated skin and skin structure infection using Bayesian methods for evidence synthesis.

Value in Health. 2011 (Article in Press DOI: 10.1016/j.jval.2010.12.006)

Vanness DJ, Knudsen AB, Lansdorp-Vogelaar I, et al. Comparative economic evaluation of the

American College of Radiology Imaging Network National CT Colonography Trial with three

CISNET microsimulations. Radiology. 2011; 261:487-498.

Chen HY, Vanness DJ and Golestanian E. A simplified score for transfer to a long-term care hospital among ventilated patients. Am J Crit Care November 2011 20:e122-e130; doi:10.4037/ajcc2011775. [Advisee First Author].

Crown W, Henk HJ and Vanness DJ. Some cautions on the use of instrumental variables (IV) estimators in outcomes research: How bias in IV estimators is affected by instrument strength, instrument contamination, and sample size. Value in Health 2011; 14(8): 1078-1084

Wasiak R, Filonenko A, Vanness DJ, et al. Impact of estradiol-valerate/dienogest on work productivity and activities of daily living in European and Australian women with heavy menstrual bleeding. Int J Womens Health 2012 Jul; 4: 271–278

Wasiak R, Filonenko A, Vanness DJ, et al. Impact of estradiol valerate/dienogest on work productivity and activities of daily living in North American women diagnosed with heavy menstrual bleeding. Int J Womens Health 2013 Apr; 22(4):378-84

Wu Y, Alagoz O, Ayvaci M, Munoz del Rio A, Vanness DJ, Woods R and Burnside ES. A comprehensive methodology for determining the most informative mammographic features.

Journal of Digital Imaging 2013 Oct; 26:941-947

Connor JT, Luce BR, Broglio KR, Ishak KJ, Mullins CD, Vanness DJ, Fleurence R. Do

Bayesian adaptive trials offer advantages for comparative effectiveness research? Protocol for the RE-ADAPT (Research in ADAptive methods for Pragmatic Trials) Study. Clinical Trials

2013 Oct; 10:807-827

25

Wu Y, Vanness DJ and Burnside ES. Using multidimensional mutual information to prioritize mammographic features for breast cancer diagnosis. AMIA Annu Symp Proc. 2013; 1534-1543.

Wu Y, Alagoz O, Vanness DJ, Trentham-Dietz A, Burnside ES. Pursuing optimal thresholds to recommend breast biopsy by quantifying the value of tomosynthesis. Proc. SPIE 9037, Medical

Imaging 2014: Image Perception, Observer Performance, and Technology Assessment, 90370U

(March 11, 2014).

Wisk LE, Gangnon R, Vanness DJ, Galbraith AA, Mullahy J and Witt WP. Development of a

Novel, Objective Measure of Health Care-Related Financial Burden for U.S. Families with

Children. Health Services Research (Best of the 2014 Academy Health Annual Research

Meeting) 2014; 49(6): 1852-1874. [Advisee First Author]

Jackson H, Mandell K, Johnson K, Chatterjee D, Vanness DJ. Cost-Effectiveness of Injectable

Extended-Release Naltrexone Compared With Methadone Maintenance and Buprenorphine

Maintenance Treatment for Opioid Dependence. Substance Abuse. 2015; 36(2): 226-231.

[Advisee First Author]

Bow EJ, Vanness DJ, Cordonnier C, Cornely OA, Marks DI, Pagliuca A, Slavin M, Solano C,

Cragin L, Shaul AJ, Sorensen S, Chambers R, Kantecki M, Weinstein D and Schlamm H.

Systematic Review and Mixed Treatment Comparison of Randomized Clinical Trials of Primary

Antifungal Prophylaxis in Allogeneic Hematopoietic Cell Transplant Recipients. BMC

Infectious Diseases 2015; 15(1): 128.

Pritts EA, Vanness DJ, Berek JS, Parker W, Feinberg R, Feinberg J, et al. The prevalence of occult leiomyosarcoma at surgery for presumed uterine fibroids: a meta-analysis. Gynecol Surg.

2015;1–13.

Gareen I, Siewert B, Vanness DJ, Herman B, Johnson CD, Gatsonis C. Patient willingness to return for repeat screening and preference for CT Colonography versus Optical Colonoscopy during the National ACRIN CT Colonography trial. Journal of Patient Preference and

Adherence 2015; 9: 1043-1051.

Pu J, Chewning BA, Johnson HM, Vanness DJ, Young HN, Kreling DH. Health behavior change after blood pressure feedback. PLOS ONE 2015 (In Press) [Advisee First Author]

Alghnam S, Vanness DJ, Gaskin DJ, Thorpe RJ and Castillo R. Estimating annual medical and out-of-pocket expenditures associated with traumatic injuries in the United States, J Trauma.

Revise and Resubmit.

Repplinger MD, Levy JF, Peethumnongsin E, Gussick ME, Svenson JE, Golden SK, Ehlenbach

WJ, Westergaard RP, Reeder SB, and Vanness DJ. Systematic Review and Meta-Analysis of the

Accuracy of MRI to Diagnose Appendicitis in the General Population. [Mentee first author] J

Med Resonance Imaging, Revise and Resubmit.

26

Manuscripts in Development:

Preussler J, Mau L, Majhail NS, Meyer C, Denzen E, Edsall K, Farnia S, Silver A, Saber W,

Burns LJ and Vanness DJ. Use of Administrative Claims Data for Cost Analyses in

Hematopoietic Cell Transplantation: Challenges and Opportunities. [Advisee first author] In

Preparation.

Decker MR, Levy JF, Wilke LG, Vanness DJ and Neuman HB. Balancing the Harms and

Benegits of Radiation Therapy for DCIS: A Decision Analysis Examining the Risk of Radiation-

Associated Sarcoma. [Advisee first author] In Preparation.

Dokow E, Luque J, Vanness DJ. A spatial model of hospital choice with endogenous jurisdiction frontiers: implications for the use of distance to hospitals as an instrumental variable. In

Preparation.

Solano C, Slavin M, Shaul AJ, Marks DI, Cordonnier C, Cornely OA, Pagliuca A, Cragin L,

Sorensen S, Vanness DJ, de Salas M, Schlamm H, Weinstein D and Bow EJ. “Economic

Evaluation of Voriconazole as Primary Prophylaxis for the Prevention of Invasive Fungal

Infections in Spanish Patients Undergoing Allogeneic Haematopoietic Cell Transplant” In

Preparation

Jackson H, Vanness DJ, Stout N, Alagoz O, Sprague B, Gangnon RE and Trentham-Dietz A.

Construction of Breast-Cancer Adjusted Cohort Life Tables for U.S. Women by Race and Body

Mass Index. [Advisee First Author] In Preparation.

Vanness DJ. A combined machine learning and Bayesian approach to identifying heterogeneous treatment effects with non-causal pharmacogenomic data. In preparation.

Vanness DJ. Recursive Partitioning Analysis of U.S. County-Level Morbidity and Mortality: The

Central Role of Child Poverty. In Preparation.

Hanmer J, Vanness DJ, Palta M, Fryback DG. Modeling the Effect of Co ‐ occurring Health

Conditions on Item Responses in the SF ‐ 36. In Preparation [Advisee First Author].

Hanmer J, Vanness DJ, Gangnon R, Palta M, Fryback DG. Does Domain ‐ Based Modeling of

Health Conditions Improve Health ‐ Related Quality of Life Estimates Compared to Summary‐

Score ‐ Based Modeling? In Preparation [Advisee First Author].

Vanness DJ, Hanmer J. Modeling Crosswalk Functions: a Bayesian Beta Regression Approach.

In Preparation.

27

Invited Articles:

Whiting JF, for the Transplant Outcomes Research Group . Standards for economic and quality of life studies in transplantation. Transplantation. 2000; 70(7): 1115-1121.

Vanness DJ. Playing (and replaying) the waiting game: Commentary on 'A simulation modeling approach to evaluating alternative policies for the management of the waiting list for liver transplant' by J. Ratcliffe and colleagues. Liver Transplantation. 2002; 8(8): 730-731.

Vanness DJ. Knowing what you don’t know: Bayesian approaches to uncertainty in economic evaluations. J Rheumatol. 2003; 68(1):23-25.

Vanness DJ. Using Bayesian Mixed Treatment Comparison Meta Analysis to Improve the

Design of Comparative Effectiveness Trials. Biopharm Report. 2010; 17(1): 2-9.

Published Books and Book Chapters:

Wolfe BL and Vanness DJ. “Inequality in Health Care Access and Utilization and the Potential

Role for the Public Sector.” In: Stein Ringen and Philip R. de Jong, (eds) Fighting Poverty:

Caring for Children, Parents, the Elderly and Health. Aldershot, England: Ashgate Publishing

Ltd., 1999.

Vanness DJ. Choice, Information and Quality of Employer-Sponsored Health Insurance.

Doctoral Dissertation, University of Wisconsin-Madison Economics, 2000.

Vanness DJ and Mullahy J. "Perspectives on Mean-based Evaluation of Health Care" In: Jones

AM (ed), Elgar Companion to Health Economics, Cheltenham: Edward Elgar Publishing, 2006.

Tosteson, ANA and Vanness DJ. “The Economics of Osteoporosis” In: Marcus R, Feldman D,

Nelson DA and Rosen CJ (eds), Osteoporosis, 3ed., Elsevier Science & Technology Books,

2007.

Vanness, DJ. “Investments in the Human Capital of Disadvantaged Populations: The Role of

Cost-Benefit and Cost-Effectiveness Analysis of Health Care” in Weimer, D and Vining A (eds),

Investing in the Disadvantaged: Assessing the Benefits and Costs of Social Policies.

Washington, D.C.: Georgetown University Press, 2009

Vanness DJ and Mullahy J. "Moving Beyond Mean-based Evaluation of Health Care" In: Jones

AM (ed), Elgar Companion to Health Economics, 2 nd ed. Cheltenham: Edward Elgar Publishing,

2012.

28

Abstracts and Research Reports:

Wolfe BL and Vanness DJ. “The Nondiscrimination law and health insurance: For whom did it increase coverage?” Abstr Book Assoc Health Serv Res Meet. 1998; 15:88.

Seplaki CL and Vanness DJ. Patterns of TCA and SSRI prescription across plans, providers, and states: Do publicly-insured managed care members receive differential treatment? Abstr Book

Assoc Health Serv Res Meet. 1999; 16:122.

Vanness DJ and Wolfe BL. “Government mandates and employer-sponsored health insurance:

Who is still not covered?” The La Follette Policy Report. 1999:10(1); 12-14, 18-19.

Seplaki CL and Vanness DJ. Patterns of TCA and SSRI prescriptions: A description of antidepressant utilization between publicly and privately insured managed care members,” J

Mental Health Policy Econ. 2000; 3 Supplement 1: S24.

Vanness DJ and Kim WR. “Cost-effectiveness of ganciclovir in prevention of cytomegalovirus after liver transplantation: A Bayesian approach” Value Health. 2000; 3(5): 326.

Fatourechi V, Schryver PG, Vanness DJ and Klee GG. Increased prevalence of mildly elevated serum TSH levels in patients with coronary heart disease compared to controls,” Endocr J. 2000;

47:193.

Lankarani M, Klee GG, Schryver PG, Vanness DJ, Long KH and Fatourechi, V. Progression of hypothyroidism in patients with mildly elevated TSH (5-10mIU/L). Endocr J. 2000; 47:193.

Kamath CC, Maradit-Kremers H, Vanness DJ, O'Fallon WM and Gabriel SE. Cost-effectiveness of drug therapies in knee osteoarthritis (OA) Medical Decision Making. 2001; 21(6): 541.

Kamath CC, Maradit-Kremers H, Vanness DJ, O’Fallon WM and Gabriel SE. Costeffectiveness of alternative drug therapies in knee osteoarthritis (OA).” Arthritis Rheumatism.

2001; 44(9): S158.

Vanness DJ and Ahlquist DA. Discrete event simulation of the cost-effectiveness of colorectal cancer screening by a DNA-based stool test relative to current screening practice. Gastroenterol.

2001; 120(5 Suppl 1): A.406.

Kim WR and Vanness DJ. Employment and health insurance of long-term liver transplant recipients (Abstract 282). Liver Transplantation. 2002; 8(6): C-71.

Huddleston J, Larson D, Vanness D, Long K, Plevak M, Ilstrup D, et al. Partnering for optimal patient care: Prospective, randomized, controlled trial of the inpatient experience of a hospitalistorthopedic team. J Gen Internal Med. 2002 Apr;17:125-125.

Vanness D, Tosteson A, Gabriel S, Khosla S, Melton L. A structural microsimulation generates type I and type II osteoporosis from estrogen deficiency. J Bone Min Res. 2005 Sep;20(9):S160-

S160.

29

Hanmer J, Gangnon R, Vanness DJ and Fryback DG. Does domain-based modeling of mutliple health conditions improve health-related quality of life estimates compared to summary-scorebased modeling for the SF-6D? Proceedings of the 29th Annual Meeting of the Society for

Medical Decision Making, 2007 [Advisee First Author].

Hanmer J, Vanness DJ, Gangnon R and Fryback DG. Modeling co-occurring health conditions to predict health utility from generic health-related quality of life indexes. Proceedings of the

29th Annual Meeting of the Society for Medical Decision Making, 2007 [Advisee First Author].

Lang K, Lines LM, Lee DW, Korn JR, Vanness DJ, Earle CC and Menzin J. Excess lifetime costs associated with colorectal cancer among elderly Medicare beneficiaries: Evidence from

SEER-Medicare data. J Clin Oncol. 2008; 26(15S): 4044

Lang K, Lines LM, Lee DW, Korn JR, Vanness DJ, Earle CC and Menzin J. Trends in stage distribution and survival among elderly colorectal cancer patients in the US. J Clin Oncol. 2008;

26(15S): 4043

Lang K, Lines LM, Lee DW, Korn JR, Vanness DJ, Earle CC and Menzin J. Trends in treatment among elderly colorectal cancer patients in the US: evidence from linked SEER-Medicare data.

Value Health. 2008; 11(3): A9

Siewert B, Gareen I, Vanness D, Herman B, Johnson CD, Gatsonis C. ACRIN 6664: Patient acceptance and preference of CT colonography compared to optical colonoscopy for colon cancer screening. ASCO Meeting Abstracts. 2009. p. 4034.

Vanness D, Roy S, Benedict A, Cifaldi M. Bayesian Generalized Linear Modelling of the

Relationship Between Health Assessment Questionnaire-Disability Index and Health Utilities

Index Mark III in Early and Late Rheumatoid Arthritis: Data from the PREMIER and ARMADA

Trials. Value Health. 2009;12(7):A227.

Vanness DJ, Singfield C, Joseph IA, van Nooten F, Agarwal K, Buti M, et al. Cost-Effectiveness

Analysis of the EASL 2009 Clinical Practice Guidelines for Management of Chronic Hepatitis B in France, Italy, Portugal, Spain, Turkey and the United Kingdom. J Hepatol. 2010;52:S398.

Vanness DJ, Hanmer J. Modeling Crosswalk Functions: a Bayesian Beta Regression Approach.

Medical Decision Making 2011; 31(1) E178.

Benedict A, Vanness DJ, Shaw JW, Cifaldi MA. Methodological issues when performing mixed treatment comparisons in rheumatoid arthritis. Annals of the Rheumatic Diseases 2014; 71(Suppl

3):453.

Pu J, Vanness D, Kreling D, Chewning B. Framingham risk score to predict subsequent coronary artery calcification in a young adult population. Circulation 2014; 129: AP332

[Advisee First Author]

Pu J, Vanness D, Kreling D, Chewning B. Health literacy and health behaviors associated with racial disparities in blood pressure. Circulation 2014; 129: AP156. [Advisee First Author]

30

Decker, MR., Levy JF, Wilke LG, Vanness DJ and Neuman HB. Abstract P6-09-06: Balancing the harms and benefits of radiation therapy for DCIS: A decision analysis examining the risk of radiation-associated sarcoma. Cancer Research 75.9 Supplement (2015): P6-09. [Advisee First

Author]

Preussler, JM, Mau L, Denzen EM, Majhail NS, Farnia SA, Silver A, Meyer C, Saber W and

Vanness DJ. Administrative Claims Data for Cost Analyses in Hematopoietic Cell

Transplantation: The Good, the Bad and the Ugly. Biology of Blood and Marrow

Transplantation 2, no. 21 (2015): S359-S360. [Advisee First Author]

Levy, JF, Rosenberg MA, and Vanness DJ. US Based Drug Cost Parameter Estimates Using

National Average Drug Acquisition Cost. Value in Health 18.3 (2015): A7. [Advisee First

Author]

Arora P, Vanness DJ, and Saber W. PMD6-Allogeneic peripheral blood versus bone marrow hematopoietic cell transplantation from unrelated donors: a meta-analysis. Value in Health 18.3

(2015): A38. [Advisee First Author]

Bounthavong M, Bae YH, Vanness DJ, Kazerooni R, and Devine B. PGI1-An evaluation of clinical remission and safety among Biologics for moderate-to-severe Crohns disease: a

Bayesian network meta-analysis. Value in Health 18, no. 3 (2015): A221-A222.

31

CURRICULUM VITAE - Department of Population Health Sciences

Related documents

Products

Support

CURRICULUM VITAE - Department of Population Health Sciences

Related documents

Add this document to collection(s)

Add this document to saved

Suggest us how to improve StudyLib